Improving Genetic Medicine for Ethnic Minority Groups
Capturing Ethnic Minority Experiences of Genomic Pathways to Understand What Changes Are Needed to Promote Greater Equity Within the Genomic Medicine Service.
1 other identifier
observational
100
1 country
1
Brief Summary
A key aim of the nationally commissioned Genomic Medicine Service (GMS) in England is to encourage equity of access between different patient groups, however, there is evidence to suggest that it is being under-utilised by ethnic minority groups. The aim of this study is to explore how ethnic minority populations interact with the GMS and to identify changes that would promote equity within those services. This is a mixed-methods study using interviews and group discussions with lay people, community organisers and charity workers, people who have had direct or indirect contact with the genomic medicine service and professionals within the service. By including potential service users, service users and professionals in this work and allowing people to share their experiences in whatever method feels most comfortable to them, we aim to get a broad understanding of the lived experience of everyone involved in these pathways which will be key to gaining a holistic understanding of how they are working in real world settings. The primary outcome measure will be an increased understanding of the experiences of people from ethnic minority groups navigating the genomic medicine space. The secondary outcome measure will be an increased understanding of how experiences differ across and between ethnic groups. We intend to use our insights to recommend structural changes which will improve utilisation of the genomic medicine service by patients from ethnic minority groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedStudy Start
First participant enrolled
January 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 30, 2031
December 30, 2025
December 1, 2025
5 years
December 16, 2025
December 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Qualitative insights into people's experiences
increased understanding of the experiences of people from ethnic minority groups navigating the genomic medicine space
5 years
Secondary Outcomes (1)
Qualitative insights into differences between minority groups
5 years
Study Arms (4)
Lay members of the public
Lay members of the public recruited from community settings
Community organisers and charity workers
Community and charity workers recruited from community settings
Patients, family members and carers
Recruited through a mixture of healthcare and community settings
Healthcare professionals
Recruited through professional networks
Eligibility Criteria
The study population is individuals who identify as being from ethnic minority backgrounds and community organisers, charity workers and health care professional who have insight into their experiences
You may qualify if:
- Adults
- Have capacity to consent to take part
You may not qualify if:
- Under 18 years of age
- Affected by a serious mental health condition
- Learning disabilities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guys and St Thomas' NHS foundation Trust
London, United Kingdom
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2025
First Posted
December 30, 2025
Study Start
January 30, 2026
Primary Completion (Estimated)
January 30, 2031
Study Completion (Estimated)
January 30, 2031
Last Updated
December 30, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- For 2 years after the end of the study.
- Access Criteria
- On application to the CI.
The protocol will be shared. No personal identifiers will be shared with other researchers, but de-identified transcripts will be shared on application to the CI.